Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Overview of attention for article published in New England Journal of Medicine, July 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Dimensions has found 10 publications that cite this research output.

Article in Journal of Antimicrobial Chemotherapy (September 2024)

Article in AIDS and Behavior (September 2024)

Article in Nature (September 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.